Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism

Mol Cell. 1998 Jan;1(2):203-11. doi: 10.1016/s1097-2765(00)80021-0.

Abstract

The c-Myb protein is controlled by intramolecular interactions, and point mutations can enhance its oncogenic activity. We tested whether conformational changes regulate c-Myb and found that Cyp-40, a widely distributed cyclophilin and peptidyl-prolyl isomerase, could inhibit c-Myb DNA binding activity. Inhibition by Cyp-40 required both its C-terminal protein-interaction domain, which bound specifically to c-Myb, and its N-terminal catalytic domain and was blocked by the competitive inhibitor cyclosporin A. Cyp-40 failed to bind or inhibit the oncogenic derivative v-Myb, which has a mutated Cyp-40 binding site. These results suggest that mutations in v-Myb allow it to evade a negative regulatory mechanism mediated by enzymes such as Cyp-40, and implicate peptidyl-prolyl isomerases in the regulation of transcription, transformation, and differentiation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Chickens
  • Cyclophilins*
  • DNA-Binding Proteins / metabolism
  • Gene Expression Regulation, Enzymologic / physiology
  • Gene Expression Regulation, Neoplastic / physiology
  • Humans
  • Jurkat Cells / chemistry
  • Jurkat Cells / enzymology
  • Molecular Sequence Data
  • Mutagenesis / physiology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Oncogene Proteins v-myb
  • Peptidyl-Prolyl Isomerase F
  • Peptidylprolyl Isomerase / genetics
  • Peptidylprolyl Isomerase / metabolism*
  • Point Mutation / physiology*
  • Protein-Tyrosine Kinases / genetics
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-myb
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Retroviridae Proteins, Oncogenic / antagonists & inhibitors
  • Retroviridae Proteins, Oncogenic / genetics*
  • Retroviridae Proteins, Oncogenic / metabolism
  • Trans-Activators / antagonists & inhibitors
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Transcription, Genetic / physiology

Substances

  • Carrier Proteins
  • Peptidyl-Prolyl Isomerase F
  • DNA-Binding Proteins
  • Nuclear Proteins
  • Oncogene Proteins v-myb
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myb
  • Recombinant Fusion Proteins
  • Retroviridae Proteins, Oncogenic
  • Trans-Activators
  • Protein-Tyrosine Kinases
  • Cyclophilins
  • Peptidylprolyl Isomerase